Skip to main content
TipRanks
Go Ultimate75% OFF

Dawnrays Pharmaceutical Holdings Ltd. (2348) Income Statement

6 Followers

Dawnrays Pharmaceutical Holdings Ltd. Income Statement

Last quarter (Q2 2026), Dawnrays Pharmaceutical Holdings Ltd.'s total revenue was ¥538.31M, a decrease of 6.78% from the same quarter last year. In Q2, Dawnrays Pharmaceutical Holdings Ltd.'s net income was ¥121.64M. See Dawnrays Pharmaceutical Holdings Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 1.23B¥ 1.06B¥ 1.15B¥ 1.28B¥ 1.17B
¥ 557.40M¥ 577.63M¥ 641.52M¥ 766.68M¥ 675.36M
¥ 327.75M¥ 209.72M¥ 199.20M¥ 344.27M¥ 293.47M
Depreciation and Amortization¥ 120.15M¥ 106.62M¥ 83.89M¥ 66.41M¥ 57.55M
¥ 347.57M¥ 308.67M¥ 498.94M¥ 505.19M¥ 438.31M
¥ 229.65M¥ 367.91M¥ 277.42M¥ 422.41M¥ 380.76M
¥ 19.96M¥ 269.04M¥ 136.64M¥ 16.00M¥ 57.43M
¥ 249.61M¥ 636.95M¥ 414.06M¥ 438.41M¥ 439.32M
¥ 213.97M¥ 564.94M¥ 326.00M¥ 358.06M¥ 358.18M
Per Share Metrics
Basic EPS¥ 0.14¥ 0.38¥ 0.22¥ 0.24¥ 0.24
Diluted EPS¥ 0.14¥ 0.38¥ 0.22¥ 0.24¥ 0.24
Weighted Average Shares Outstanding1.50B1.51B1.50B1.50B1.50B
Weighted Average Shares Outstanding (Diluted)1.50B1.51B1.50B1.50B1.51B

Currency in CNY

Dawnrays Pharmaceutical Holdings Ltd. Earnings and Revenue History

0500M1B1.5B15 %30 %45 %60 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin